Vital Health Podcast
Health & Wellness Podcasts
Duane Schulthess is the CEO of Vital Transformation, host and producer of Vital Health Podcast. Vital Transformation understands the implications of new medical procedures, technologies and regulations. We measure their impact upon treatment pathways and the biopharma innovation ecosystem in collaboration with health care professionals, researchers, and regulators. Through our web platform and client network, we are able to communicate our findings with international decision makers and stakeholders.
Location:
United States
Description:
Duane Schulthess is the CEO of Vital Transformation, host and producer of Vital Health Podcast. Vital Transformation understands the implications of new medical procedures, technologies and regulations. We measure their impact upon treatment pathways and the biopharma innovation ecosystem in collaboration with health care professionals, researchers, and regulators. Through our web platform and client network, we are able to communicate our findings with international decision makers and stakeholders.
Twitter:
@VitalTransform
Language:
English
Douglas Holtz-Eakin, “Indications are going to be deeply affected by the IRA”
Duration:00:54:59
John LaMattina – Drug Price Controls and IP Attacks Get Real
Duration:00:32:43
Kate Hudson & Joseph P. Allen – The Fact Free Attacks on IP
Duration:00:35:41
VT’s Grumpy Old Men – The Administration’s Threats to use March-In Rights
Duration:00:53:48
PRIME-ROSE: The EU’s DRUP Trial Champion
Duration:00:25:44
Peter Kolchinsky - "IRA's 9 Years Is Too Short"
Duration:00:56:37
Christian Schneider, CMO Biopharma Excellence
Duration:00:49:05
Bettina Ryll at the 2023 ESMO Conference
Duration:00:40:37
Dan Leonard, Executive Director, We Work For Health
Duration:00:36:18
Cancer Drug Developer Dr. Steve Potts' Congressional Testimony on the IRA
Duration:00:41:06
Amy Miller and the PhRMA Foundation Push the R&D Envelope
Duration:00:38:15
VT’s Grumpy Old Men on Price Controls and IP Attacks
Duration:00:54:23
Taking the Helm Mid Drug Pricing Maelstrom
Duration:00:32:14
Best-of Edition: Looking back on the COVID-19 outbreak part 2
Duration:00:39:22
Best-of Edition: Looking back on the COVID-19 outbreak
Duration:00:47:30
CMS' Restrictions on Alzheimer's Drugs
Duration:00:40:53
Biocom California Grapples with Regulatory Assaults on all Fronts
Duration:00:42:54
Amitabh Chandra - IRA’s potential impact on the US biopharma ecosystem
Duration:00:39:23
NJ’s Biopharma Sector in a Price Controlled World
Duration:00:17:24
IRA’s Impact on Orphan Therapies – David Meeker
Duration:00:35:37